Lilly Zyprexa off-label use
Lilly warns against Zyprexa off-label use in a Jan. 15 letter to physicians. The letter notes increased incidence of mortality and cerebrovascular events in elderly dementia patients...
You may also be interested in...
FDA is asking manufacturers of atypical antipsychotics to add a "black box" warning to labeling on an increased mortality risk associated with the drugs' off-label use to treat dementia-related behavioral disorders
Tests used to detect cytomegalovirus in organ transplant patients may face an easier path to market under a proposed rule that the US Food and Drug Administration released on 18 September. See what the regulatory agency said about it here.
While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.